Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 May;38(5):1157–1160. doi: 10.1128/aac.38.5.1157

Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole.

F T Chan 1, M X Guan 1, A M Mackenzie 1, F Diaz-Mitoma 1
PMCID: PMC188168  PMID: 8067755

Abstract

Susceptibility testing was performed on Dientamoeba fragilis ATCC 30948 in a dixenic culture with Klebsiella pneumoniae and Bacteroides vulgatus. D. fragilis was cocultured with the bacteria in TYGM-9 medium (ATCC medium 1171). The activities of antiparasitic drugs were assessed by counting viable D. fragilis trophozoites with a hemacytometer by trypan blue exclusion. The minimal amebicidal concentrations of the following four drugs were determined: iodoquinol at 128 micrograms/ml, paromomycin at 16 micrograms/ml, tetracycline (questionably) at 32 micrograms/ml, and metronidazole at 32 micrograms/ml.

Full text

PDF
1157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BALAMUTH W. Comparative action of selected amebicidal agents and antibiotics against several species of human intestinal amebae. Am J Trop Med Hyg. 1953 Mar;2(2):191–205. doi: 10.4269/ajtmh.1953.2.191. [DOI] [PubMed] [Google Scholar]
  2. BURROWS R. B., SWERDLOW M. A. Enterobius vermicularis as a probable vector of Dientamoeba fragilis. Am J Trop Med Hyg. 1956 Mar;5(2):258–265. doi: 10.4269/ajtmh.1956.5.258. [DOI] [PubMed] [Google Scholar]
  3. Bolton R. P., Culshaw M. A. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut. 1986 Oct;27(10):1169–1172. doi: 10.1136/gut.27.10.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bruckner D. A., Garcia L. S., Voge M. Intestinal parasites in Los Angeles, California. Am J Med Technol. 1979 Dec;45(12):1020–1022. [PubMed] [Google Scholar]
  5. Chan F. T., Guan M. X., Mackenzie A. M. Application of indirect immunofluorescence to detection of Dientamoeba fragilis trophozoites in fecal specimens. J Clin Microbiol. 1993 Jul;31(7):1710–1714. doi: 10.1128/jcm.31.7.1710-1714.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Diamond L. S., Harlow D. R., Cunnick C. C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 1978;72(4):431–432. doi: 10.1016/0035-9203(78)90144-x. [DOI] [PubMed] [Google Scholar]
  7. Diamond L. S. Improved method for the monoxenic cultivation of Entamoeba histolytica Schaudinn, 1903 and E. histolytica-like amebae with trypanosomatids. J Parasitol. 1968 Aug;54(4):715–719. [PubMed] [Google Scholar]
  8. Gillin F. D., Diamond L. S. Clonal growth of Entamoeba histolytica and other species of Entamoeba in agar. J Protozool. 1978 Nov;25(4):539–543. doi: 10.1111/j.1550-7408.1978.tb04182.x. [DOI] [PubMed] [Google Scholar]
  9. Johnson P. J. Metronidazole and drug resistance. Parasitol Today. 1993 May;9(5):183–186. doi: 10.1016/0169-4758(93)90143-4. [DOI] [PubMed] [Google Scholar]
  10. Kean B. H., Malloch C. L. The neglected ameba: dientamoeba fragilis. A report of 100 "pure" infections. Am J Dig Dis. 1966 Sep;11(9):735–746. doi: 10.1007/BF02239427. [DOI] [PubMed] [Google Scholar]
  11. Levine N. D., Corliss J. O., Cox F. E., Deroux G., Grain J., Honigberg B. M., Leedale G. F., Loeblich A. R., 3rd, Lom J., Lynn D. A newly revised classification of the protozoa. J Protozool. 1980 Feb;27(1):37–58. doi: 10.1111/j.1550-7408.1980.tb04228.x. [DOI] [PubMed] [Google Scholar]
  12. Millet V., Spencer M. J., Chapin M., Stewart M., Yatabe J. A., Brewer T., Garcia L. S. Dientamoeba fragilis, a protozoan parasite in adult members of a semicommunal group. Dig Dis Sci. 1983 Apr;28(4):335–339. doi: 10.1007/BF01324950. [DOI] [PubMed] [Google Scholar]
  13. Spencer M. J., Chapin M. R., Garcia L. S. Dientamoeba fragilis: a gastrointestinal protozoan infection in adults. Am J Gastroenterol. 1982 Aug;77(8):565–569. [PubMed] [Google Scholar]
  14. Spencer M. J., Garcia L. S., Chapin M. R. Dientamoeba fragilis. An intestinal pathogen in children? Am J Dis Child. 1979 Apr;133(4):390–393. [PubMed] [Google Scholar]
  15. Steinitz H., Talis B., Stein B. Entamoeba histolytica and Dientamoeba fragilis and the syndrome of chronic recurrent intestinal amoebiasis in Israel. Digestion. 1970;3(3):146–153. doi: 10.1159/000197025. [DOI] [PubMed] [Google Scholar]
  16. Talis B., Stein B., Lengy J. Dientamoeba fragilis in human feces and bile. Isr J Med Sci. 1971 Sep;7(9):1063–1069. [PubMed] [Google Scholar]
  17. Yang J., Scholten T. Dientamoeba fragilis: a review with notes on its epidemiology, pathogenicity, mode of transmission, and diagnosis. Am J Trop Med Hyg. 1977 Jan;26(1):16–22. doi: 10.4269/ajtmh.1977.26.16. [DOI] [PubMed] [Google Scholar]
  18. Zierdt C. H. Blastocystis hominis--past and future. Clin Microbiol Rev. 1991 Jan;4(1):61–79. doi: 10.1128/cmr.4.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES